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Edited by Vladimir SkulachevAbstract Expression of the multidrug resistance (MDR) trans-
porter P-glycoprotein (P-gp) has been demonstrated to be regu-
lated by hypoxia-inducible factor-1a (HIF-1a) and inhibited by
intracellular reactive oxygen species (ROS). Herein, P-gp and
HIF-1a expression were investigated in multicellular prostate
tumor spheroids overexpressing the ROS-generating enzyme
Nox-1 in comparison to the mother cell line DU-145. In Nox-1-
overexpressing tumor spheroids (DU-145Nox1) generation of
ROS as well as expression of Nox-1 was signiﬁcantly increased
as compared to DU-145 tumor spheroids. ROS generation was
signiﬁcantly inhibited in the presence of the NADPH-oxidase
antagonists diphenylen-iodonium chloride (DPI) and 4-(2-amino-
ethyl)benzenesulfonyl ﬂuoride (AEBSF). Albeit growth kinetic of
DU-145Nox1 tumor spheroids was decreased as compared to
DU-145 spheroids, elevated expression of Ki-67 was observed
indicating increased cell cycle activity. In DU-145Nox1 tumor
spheroids, expression of HIF-1a as well as P-gp was signiﬁcantly
decreased as compared to DU-145 spheroids, which resulted in an
increased retention of the anticancer agent doxorubicin. Pretreat-
ment with the free radical scavengers vitamin E and vitamin C
increased the expression of P-gp as well as HIF-1a in Nox-1-over-
expressing cells, whereas no eﬀect of free radical scavengers was
observed onmdr-1mRNA expression. In summary, the data of the
present study demonstrate that the development of P-gp-mediated
MDR is abolished under conditions of elevated ROS levels, sug-
gesting that the MDR phenotype can be circumvented by modest
increase of intracellular ROS generation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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doi:10.1016/j.febslet.2005.06.078the ABC cassette family of transporters, e.g. P-gp, MDR-asso-
ciated protein (MRP), lung resistance protein, and breast can-
cer-related protein is currently the main cause for the failure of
chemotherapeutic cancer treatment [3,15,16]. We have recently
demonstrated that intrinsic expression of P-gp in three-dimen-
sional tissues of multicellular tumor spheroids is correlated to
hypoxia in central areas of the tumor tissue [28,31]. This may
correspond to the well known chemoresistance of hypoxic tu-
mors which results in a poorer prognosis of solid tumors with
hypoxic regions than their well-oxygenated counterparts [12].
Consequently, we and others showed that P-glycoprotein (P-
gp) expression is regulated by the transcription factor HIF-1a
which is induced under conditions of hypoxia [8,31]. Under
normoxia the HIF-1a subunit is subjected to oxygen-dependent
ubiquitination and proteasomal degradation that is mediated
by the von Hippel–Lindau protein [20]. HIF-1a ubiquitination
and degradation might also be regulated by redox modiﬁca-
tions of the protein. Iron regulatory protein 2 is targeted for
ubiquitination and proteasomal degradation by oxidative mod-
iﬁcations that occur in the presence of iron and oxygen [14].
Low levels of reactive oxygen species (ROS) have been impli-
cated as intracellular signaling molecules in cellular processes
such as proliferation, apoptosis, and senescence [19]. It is
known for many years that cancer cells own the capacity to
endogenously generate ROS to signiﬁcant amounts which
may be one or the only cause of their excessive growth [23].
We have previously shown that small exponentially growing tu-
mor spheroids are active in ROS generation which is downreg-
ulated upon development of quiescent cell layers and initiation
ofMDR in the depth of large tumors [32]. Recently, it was dem-
onstrated that the superoxide-generating oxidase Nox-1 is
functionally required for ras oncogene transformation [17].
Furthermore, it was shown that NOX5 NADPH oxidase regu-
lates growth and apoptosis in DU-145 prostate cancer cells [4].
The present study was undertaken to evaluate whether overex-
pression of Nox-1 with the consequence of elevated intracellu-
lar ROS levels would aﬀect HIF-1a and P-gp levels as well as
the development of a MDR phenotype. P-gp expression has
been recently demonstrated by us and others to be regulated
by exogenously added prooxidants [9,24,32]. Apparently, low
levels of ROS downregulate P-gp expression whereas high con-
centrations of prooxidants which cause oxidative stress result inblished by Elsevier B.V. All rights reserved.
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apoptotic properties of the P-gp transporter [5]. Our data show
that overexpression of Nox-1 in DU-145 prostate cancer cells
downregulated HIF-1a as well as P-gp expression, and pre-
vented the development of a MDR phenotype. This eﬀect is re-
versed in the presence of antioxidants which result in
upregulation of HIF-1a as well as P-gp expression. The data
of the present study shed new light on the ROS-linked regula-
tion of P-gp, and should be considered in approaches that use
anti-oxidants for cancer treatment in patients.2. Materials and methods
2.1. Culture technique of multicellular tumor spheroids
The human prostate cancer cell line DU-145 as well as the DU-
145Nox1 cell line overexpressing Nox-1 [1] were used throughout the
whole study. The cell lines were grown routinely in 5% CO2, humidiﬁed
air at 37 C with Hams F-10 medium (Biochrom, Berlin, Germany)
supplemented with 10% fetal calf serum (Sigma, Deisenhofen, Ger-
many), 2 mM glutamine, 0.1 mM b-mercaptoethanol, 2 mM minimal
essential medium, 100 IU/ml penicillin, and 100 lg/ml streptomycin
(Invitrogen, Karlsruhe, Germany). Tumor spheroids were grown from
single cells. Cell monolayers were enzymatically dissociated with 0.1%
trypsin, 0.05% EDTA, and seeded in siliconized 250-ml spinner ﬂasks
(Integra Biosciences, Fernwald, Germany) with 250 ml of complete
medium and agitated at 20 rotations per minute using a Cell-spin stir-
rer system (Integra Biosciences). Cell culture medium was partially
(100 ml) changed every day.2.2. Apoptosis and cell vitality assay
Apoptosis was assessed by annexin V staining using FITC-labeled
annexin V (BD Pharmingen, San Diego, CA). Brieﬂy, cells were incu-
bated with 2 ll/ml annexin V solution for 15 min and ﬂuorescence re-
corded at 488-nm excitation. For positive controls, cells were treated
for 8 h with 2% dimethyl sulfoxide (DMSO). Cell lethality was assessed
by the use of the lethal dye Sytox green (Molecular Probes, Eugene,
OR) which labels the cell nuclei of dead cells with compromised cell
membranes. For positive controls, cells were ﬁxed with methanol prior
to labeling with 100 nM Sytox green for 15 min. Sytox green ﬂuores-
cence was excited at 488-nm.2.3. Measurement of ROS generation
Intracellular ROS levels were measured using the ﬂuorescent dye
2 0,7 0-dichlorodihydroﬂuorescein diacetate (H2DCF-DA) (Molecular
Probes, Eugene, OR), which is a non-polar compound that is con-
verted into a non-ﬂuorescent polar derivative (H2DCF) by cellular
esterases after incorporation into cells. H2DCF is membrane imperme-
able and is rapidly oxidized to the highly ﬂuorescent 2 0,7 0-dichloroﬂu-
orescein (DCF) in the presence of intracellular ROS. For the
experiments, multicellular tumor spheroids were incubated in E1 med-
ium (containing in mM: NaCl 135, KCl 5.4, CaCl2 1.8, MgCl2 1, glu-
cose 10, HEPES 10 (pH 7.4 at 23 C)), and 20 lM H2DCF-DA
dissolved in DMSO was added. After 20 min, intracellular DCF ﬂuo-
rescence (corrected for background ﬂuorescence) was evaluated in
3600 lm2 regions of interest using an overlay mask unless otherwise
indicated. For ﬂuorescence excitation, the 488-nm band of the argon
ion laser of a confocal laser scanning microscope (LSM410, Carl Zeiss,
Jena, Germany) was used. Emission was recorded using a longpass LP
515-nm ﬁlter set.2.4. Immunohistochemistry
Immunohistochemistry was performed with whole mount multicel-
lular tumor spheroids. As primary antibodies the mouse polyclonal
anti-mdr1 (clone Ab1) (Calbiochem, Bad Soden, Germany) (concen-
tration of 2 lg/ml), the mouse monoclonal anti-HIF-1a antibody
(BD Biosciences, Heidelberg, Germany) (dilution 1:200), the goat
anti-human Nox1 (Santa Cruz Biotechnology, Santa Cruz, CA), and
the mouse anti-human Ki-67 (Sigma) were used. Prior to incubationwith primary antibodies tissues were ﬁxed in 4% paraformaldehyde
for 60 min at 4 C and washed with PBS containing 1% Triton X-
100 (PBST). Blocking against unspeciﬁc binding was performed for
60 min with 10% fat free milk powder (Heirler, Radolfzell, Germany)
dissolved in PBST (0.01%). For P-gp staining, the tissues were subse-
quently incubated for 120 min at room temperature with primary anti-
bodies dissolved in PBST (0.01%) supplemented with 10% milk
powder. The tissues were thereafter washed three times with PBST
(0.01% Triton) and reincubated with either a Cy3-conjugated goat
anti-rabbit IgG (H + L) (P-gp), a Cy2-conjugated goat anti-mouse
IgG (HIF-1a), a Cy5-conjugated donkey anti-goat (Nox-1) or a Cy5-
conjugated goat anti-mouse IgG (Ki-67) (all from Dianova, Hamburg,
Germany) at a concentration of 3.8 lg/ml in PBS containing 10% milk
powder. After washing three times in PBST (0.01% Triton), the tissues
were stored in PBST (0.01%) until inspection. For the excitation of the
Cy2 ﬂuorochrome, the 488-nm band of a helium/neon laser of the con-
focal setup was used. Emission was recorded using a 515-nm longpass
ﬁlter set. The Cy3 ﬂuorochrome was excited by the 543-nm band of a
helium/neon laser and emission was recorded using a 570-nm longpass
ﬁlter set. The Cy5 ﬂuorochrome was excited with the 633-nm band of a
helium/neon laser and emission recorded using a longpass 655-nm ﬁlter
set.2.5. Doxorubicin uptake experiments
Tumor spheroids were incubated in F10 cell culture medium supple-
mented with 10 lM doxorubicin for 4 h either in the presence of ab-
sence of the P-gp-reversing agent cyclosporin A (10 lM).
Doxorubicin ﬂuorescence was excited by the 543-nm line of a he-
lium/neon laser of the confocal setup. Emission was recorded using a
LP 570-nm ﬁlter set.2.6. Quantitative RT-PCR
Total RNA from homogenized DU-145/DU-145Nox1 multicellular
tumor spheroid samples was prepared using Trizol (Invitrogen)
according to the manufacturers recommendations followed by geno-
mic DNA digestion using DNAse I/amp. grade (Invitrogen). Total
RNA concentration was determined by OD260nm method. cDNA syn-
thesis was carried out using SuperScript II RTase Kit (Invitrogen) and
random hexamer primer according to the manufacturers recommen-
dations.
Primers were designed using the free online tool primer 3 (http://fro-
do.wi.mit.edu/cgibin/primer3/primer3_www.cgi) and analyzed using
netprimer (Premier Biosoft; http://www.premierbiosoft.com/netpri-
mer/netprlaunch/netprlaunch.html) and BLAST (http://www.ncbi.
nlm.nih.gov/BLAST/). The forward sequence of mdr-1 was 5 0-AAG-
GAAGCCAATGCCTATGA-3 0 and the reverse sequence 5 0-AC-
CACTGCTTCGCTTTCTGT-3 0.
PCR was performed in an MJResearch Opticon II in 96-well micro-
titre plates using QuantiTect SYBR Green PCR kit according to the
manufacturers recommendations. In brief, cDNA product of 25 ng to-
tal RNA was mixed with QuantiTect SYBR Green PCR mastermix.
Primers were added to a ﬁnal concentration of 0.3 lM and water
was added to a ﬁnal volume of 20 ll. Ampliﬁcations were performed
starting with a 15-min template denaturation/hot start step at 95 C,
followed by 40 cycles of denaturation at 94 C for 30 s, primer anneal-
ing for 40 s at 59 C, and extension for 30 s at 75 C. Fluorescence in-
crease of SYBR Green was automatically measured after each
extension step. The last cycle was followed by a melting curve analysis
step from 55 to 95 C.
Each test was carried out three times. CT values were automatically
obtained. PCR eﬃciency was determined using the LinReg applet
(http://www.gene-quantiﬁcation.de/ramakers-2003.pdf). Relative
expression values were obtained by normalizing CT values of the tested
genes with CT values of the housekeeping gene RNA-Polymerase II
(hRPOLII) using the CT Method [18].2.7. Statistical analysis
Data are given as mean values ± S.E.M. with n denoting the number
of experiments unless otherwise indicated. In each experiment, at least
30 tumor spheroids were analyzed. Students t test for unpaired
data were applied as appropriate. A value of P < 0.05 was considered
signiﬁcant.
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3.1. Overexpression of Nox-1 in DU-145 cells increases ROS
generation of multicellular tumor spheroids
Du-145 prostate cancer cells were transfected with Nox-1 as
previously described [1]. Nox is a homologue of gp91phox, the
catalytic subunit of the phagocyte superoxide-generating
NADPH oxidase which constitutively produces both superox-
ide and hydrogen peroxide when overexpressed in ﬁbroblasts
[22]. After cultivating DU-145Nox1 cells as multicellular tu-
mor spheroids increased expression of Nox-1 protein as quan-
tiﬁed by semiquantitative immunohistochemistry was observed
as compared to the mother cell line DU-145 (Fig. 1A) (n = 3).
The highest levels of Nox-1 expression was found in small 3 to
6-day-old tumor spheroids, whereas expression decreased in
larger tumor spheroids which are known to develop central
areas of quiescent, cell-cycle-inactive cells [30]. Downregula-
tion of the expression of NADPH oxidase subunits p47-phox
and p67-phox in the parental DU-145 cell line with increasing
tumor spheroid size has been previously shown by us [32].
Concomitant to the elevated Nox-1 expression DU-145Nox1
tumor spheroids displayed signiﬁcantly increased ROS genera-
tion as evaluated by use of the redox-sensitive ﬂuorescence dyere
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Fig. 1. Increased Nox-1 expression (A) and generation of ROS (B) in
multicellular DU-145 and DU-145Nox1 tumor spheroids. Nox-1
expression was evaluated in 3–6-, 13–16-, and 25–30-day-old tumor
spheroids by semiquantitative immunohistochemistry. Intracellular
ROS were assessed by use of the redox-sensitive indicator H2DCF-DA
in the absence or presence of the NADPH oxidase inhibitors DPI
(10 lM) and AEBSF (100 lM). Note, that Nox-1 expression decreased
with increasing age of tumor spheroids. *P < 0.05 signiﬁcantly diﬀerent
as compared to the DU-145 tumor spheroids.H2DCFDA. ROS generation was signiﬁcantly inhibited by the
non-speciﬁc NADPH oxidase inhibitors DPI (10 lM) and
AEBSF (100 lM) (n = 3) (see Fig. 1B).3.2. Overexpression of Nox-1 in DU-145 cells increases
proliferation but not growth of multicellular tumor spheroids
It has been previously shown that H2O2 generated upon
expression of Nox-1 in NIH 3T3 ﬁbroblasts mediated cell
growth and transformation [2]. Furthermore, cell proliferation
in vitro as well as tumor growth after implantation in mice was
increased in Nox-1 overexpressing DU-145 [1]. We have previ-
ously demonstrated that P-gp expression increases with the
emergence of quiescent, cell-cycle-inactive cell areas which de-
velop with prolonged cell culture of tumor spheroids [28]. It
was therefore hypothesized that cell proliferation as investi-
gated by the expression of the proliferation-associated marker
Ki-67 would be increased in DU-145Nox1 tumor spheroids at
diﬀerent times of tumor spheroid culture. In parallel to the
analysis of Ki-67 expression growth curves of tumor spheroids
of the parent cell line DU-145 and DU-145Nox1 tumor spher-
oids were determined. According to our assumptions, Ki-67
expression was signiﬁcantly increased in DU-145Nox1 tumor
spheroids as compared to DU-145 tumor spheroids in all
investigated ages of tumor spheroid culture and decreased with
prolonged cell culture times (Fig. 2A) (n = 3). However, when
tumor spheroid growth was assessed, the tumor spheroid vol-
umes of DU-145Nox1 spheroids were signiﬁcantly decreased
as compared to DU-145 spheroids of the respective age
(Fig. 2B) (n = 3). This is likely due to apparent shaling of loose
peripheral cells from the surface of DU-145Nox1 tumor spher-
oids by shear stress occurring during spinner ﬂask culture
(data not shown).
To investigate whether peripheral cells shaled from the sur-
face of DU-145Nox1 tumor spheroids were vital, apoptosis in
single cells was assessed by Annexin V labeling and cell death
by staining with the lethal dye Sytox green, which is cell mem-
brane impermeant and accumulates in cell nuclei of cells with
compromised cell membranes. When single cells shaled from
the periphery of tumor spheroids were plated to coverslips,
they attached to the glass surface within minutes, started to
proliferate after few hours, and displayed intracellular calcium
responses after stimulation with ATP (data not shown). As
shown in Fig. 3, the cells were annexin V and Sytox green neg-
ative, indicating that they were vital with no signs of apoptosis.3.3. Nox-1 overexpressing cells display reduced protein levels of
P-gp
The working hypothesis of the present study suggests that
elevated ROS generation in DU-145Nox1 tumor spheroids
prevents expression of the MDR transporter P-gp which was
previously demonstrated to be upregulated in large, cell-cy-
cle-inactive DU-145 tumor spheroids displaying decreased
ROS generation [28,32]. To evaluate this issue, P-gp expression
was assessed during the growth of DU-145 as well as DU-145-
Nox1 tumor spheroids by semiquantitative immunohisto-
chemistry. As previously reported P-gp expression was tran-
siently increased during tumor spheroid growth of DU-145
cells with a maximum occurring around day 10 of cell culture.
A comparable time course of P-gp expression was likewise ob-
tained in DU-145Nox1 tumor spheroids. However, the expres-
sion level of P-gp in DU-145Nox1 spheroids was signiﬁcantly
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Fig. 2. Expression of the proliferation marker Ki-67 (A) and growth
(B) of DU-145 and DU-145Nox1 multicellular tumor spheroids. Ki-67
expression was signiﬁcantly increased in all age classes of DU-
145Nox1 tumor spheroids under investigation but decreased during
the growth of tumor spheroids. The size of DU-145Nox1 tumor
spheroids was decreased as compared to the parental cell line which is
presumably due to the shaling of loosely attached cells from the surface
of DU-145Nox1 tumor spheroids. *P < 0.05 signiﬁcantly diﬀerent as
compared to the DU-145 tumor spheroids.
4544 M. Wartenberg et al. / FEBS Letters 579 (2005) 4541–4549lower in all ages of tumor spheroids under investigation
(Fig. 4) (n = 30 tumor spheroids in each data point).
3.4. Overexpression of Nox-1 in DU-145 prevents induction of
the MDR phenotype
The decreased expression level of P-gp in DU-145Nox1 tu-
mor spheroids should result in the development of a MDR
phenotype, i.e. in reduced drug uptake due to P-gp-mediated
drug export. To investigate development of a MDR pheno-
type, multicellular tumor spheroids were incubated with the
P-gp substrate doxorubicin (10 lM), and doxorubicin uptake
was evaluated in the absence and presence of the P-gp-revers-
ing agent cyclosporin A (10 lM) after 4 h of incubation
(Fig. 5) (n = 3). Doxorubicin ﬂuorescence was signiﬁcantly de-
creased in DU-145 tumor spheroids as compared to DU-
145Nox1 spheroids which is due to increased doxorubicin
export. As previously shown [32] incubation with the P-gp-
reversing agent cyclosporin A signiﬁcantly increased doxorubi-
cin retention in the parent DU-145 cell line indicating the
presence of P-gp-mediated MDR in DU-145 prostate tumor
spheroids (n = 3). In contrast, doxorubicin uptake in the pres-ence of cyclosporin A was not signiﬁcantly increased in DU-
145Nox1 tumor spheroids which is presumably due to the de-
creased expression level of P-gp in this cell line.
3.5. Upregulation of HIF-1a and P-gp upon incubation of
DU-145Nox1 tumor spheroids with free radical scavengers
The data of the present study demonstrate that Nox-1 over-
expression prevents the development of the MDR phenotype
which is observed in large tumor spheroids of the parental cell
line DU-145. Since we and others have previously shown that
P-gp expression is under the control of HIF-1a [8,31] we as-
sumed that HIF-1a would likewise be decreased in the DU-
145Nox1 cell line. Furthermore, preincubation with free radi-
cal scavengers should result in upregulation of HIF-1a as well
as P-gp expression. To verify the assumption that the de-
creased expression of HIF-1a as well as P-gp in DU-
145Nox1 tumor spheroids was due to increased ROS genera-
tion in DU-145Nox1 cells, tumor spheroids were incubated
from day 6 to day 14 with the free radical scavengers vitamin
C (30 lM) and vitamin E (100 lM). Subsequently P-gp as well
as HIF-1a expression was assessed (Fig. 6A and B). Preincuba-
tion for 7 days in vitamin C/E containing cell culture medium
signiﬁcantly increased HIF-1a (see Fig. 6A) as well as P-gp (see
Fig. 6B) expression in the DU-145Nox1 tumor spheroids but
not in the DU-145 tumor spheroids. This clearly indicates that
the increased ROS levels in DU-145Nox1 tumor spheroids pre-
vented the development of the P-gp-mediated MDR pheno-
type.
To investigate whether incubation with free radical scaveng-
ers changed mRNA expression, quantitative RT-PCR was per-
formed with tumor spheroids of the DU-145 as well as the
DU-145Nox1 cell line. It was observed that incubation with
free radical scavengers did not signiﬁcantly increase mdr-1
mRNA expression in DU-145 as well as DU-145Nox1 tumor
spheroids which strongly suggests that the eﬀects of ROS on
P-gp expression are due to changes in protein turnover
(Fig. 7) (n = 3).4. Discussion
Previous studies of our group have demonstrated that low
concentrations of exogenously added prooxidants downregu-
lated P-gp expression and reversed the MDR phenotype in
DU-145 prostate tumor spheroids [26,31]. The MDR pheno-
type in tumor spheroids of diﬀerent origin was shown to devel-
op at times when the exponential growth of tumor spheroids
attains a plateau phase and quiescent, cell-cycle-inactive cell
areas are present in the deeper layers of the tumor tissue which
is paralleled by the development of central hypoxia and down-
regulation of ROS generation [28,32]. The coherence between
elevated ROS generation and cell-cycle progression is mean-
while well established. It has been shown in a variety of studies
that ROS play a role in many growth factor- and cytokine-
mediated signaling cascades [19]. Furthermore, the aggressive
growth of a variety of tumor cells is well known to be associ-
ated with increased generation of ROS [23]. Transformation of
NIH 3T3 cells with constitutively active Ras resulted in ele-
vated ROS generation and increased cell-cycle activity suggest-
ing ROS as mediators of Ras-induced cell-cycle progression
[13]. Additionally, overexpression of the gp91phox homologue
Fig. 3. Cell vitality of single cells shaled from the periphery of DU-145Nox1 tumor spheroids. Apoptosis was assessed by annexin V staining and cell
lethality by labeling of cell nuclei with Sytox green. Annexin V labeling was negligible in control tumor spheroids (a), indicating absence of apoptosis,
whereas a prominent staining was observed when apoptosis was induced by DMSO (1%) treatment for 8 h (b) (d, e represent transmission images of
a, b, respectively). Systox green staining was absent in control cells, as shown in an overlay between a transmission image and a Sytox green
ﬂuorescence image (f), indicating that cells were vital. In contrast, staining of cell nuclei was obvious when cells were killed by methanol ﬁxation (c).
The bar represents 20 lm.
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Fig. 4. Expression of P-gp during the growth of DU-145 and DU-
145Nox1 tumor spheroids as evaluated by semiquantitative immuno-
histochemistry. P-gp displayed transient expression in tumor spheroids
of both cell lines. However, P-gp was signiﬁcantly decreased in DU-
145Nox1 tumor spheroids of all ages under investigation.
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increased mitotic rate, cell transformation and tumorigenicity
[2]. In previous studies, we have shown that during the expo-
nential growth phase of tumor spheroids the cells are express-
ing NADPH oxidase and robustly generate ROS. Upon
induction of cell quiescence and decay in tumor growth ROS
generation as well as expression of NADPH oxidase was
downregulated [32]. These previous observations led to the
hypothesis that expression of P-gp is linked to the intracellular
ROS level of the tumor cells.In the present study, it was shown that DU-145Nox1 tumor
spheroids displayed elevated levels of ROS as compared to the
parent cell line DU-145. Nox-1 expression in DU-145Nox1 tu-
mor spheroids decreased with prolonged cell culture time
which was paralleled by downregulation of the proliferation
marker Ki-67. Comparable eﬀects were obtained in the paren-
tal cell line DU-145 albeit the expression of Nox-1 as well as
Ki-67 was at a lower level as compared to DU-145Nox1 tumor
spheroids at each age class investigated. This indicates that
NADPH-oxidase expression is closely associated with cell-
cycle activity of the tumor cells. In this respect, it has been
recently demonstrated that Nox-2 deﬁciency in mice led to re-
duced cellular proliferation and leukocyte accumulation [6].
The control of P-gp expression by the proliferation status of
cells is still highly controversial. Previously, it has been shown
that MDR is expressed on cell-cycle-inactive human hemato-
poietic progenitors and leukemic blasts. Proliferation induc-
tion of the cells resulted in increased anthracycline
sensitivity, i.e. reversal of the MDR phenotype [21]. In a fur-
ther study, it was shown that P-gp turnover is a cell-cycle-re-
lated process in MDR cells since P-gp half-life was
considerably increased when the cell cycle of cancer cells was
delayed in the G0/G1 phase [34]. These data were corroborated
by a recent study of us which demonstrated that experimental
arrest of DU-145 tumor spheroids in the G0/G1 phase resulted
in parallel upregulation of P-gp and the cyclin-dependent ki-
nase inhibitor p27kip1 [27].
The working hypothesis of the present study assumed that
the increased ROS generation in DU-145Nox1 tumor spher-
oids would depress P-gp expression. To verify this assumption
P-gp expression was monitored during the growth of DU-
145Nox1 and DU-145 tumor spheroids. Although a transient
expression of P-gp was observed in DU-145Nox1 as well as
Fig. 5. Uptake of the P-gp substrate doxorubicin (10 lM) in tumor spheroids of the DU-145 and DU-145Nox1 cell line. Doxorubicin (10 lM)
uptake after 4 h was signiﬁcantly lower in DU-145 tumor spheroids as compared to DU-145Nox1 tumor spheroids, indicating absence of a MDR
phenotype in the latter cell line. Preincubation with the P-gp-reversing agent cyclosporin A (10 lM) increased doxorubicin uptake in drug resistant
DU-145 tumor spheroids but not in drug-sensitive DU-145Nox1 spheroids. The bar represents 200 lm. *P < 0.05 signiﬁcantly diﬀerent as compared
to the DU-145 tumor spheroids.
4546 M. Wartenberg et al. / FEBS Letters 579 (2005) 4541–4549in DU-145 tumor spheroids the expression level of P-gp was
signiﬁcantly decreased in the DU-145Nox1 cell line as com-
pared to DU-145 cells, which strongly suggests that P-gp
expression is regulated by the intracellular ROS level. In-
creased P-gp expression should result in the development of
a MDR phenotype resulting in decreased drug uptake. Indeed,
it was observed that doxorubicin uptake was decreased in DU-
145 tumor spheroids as compared to spheroids of the DU-
145Nox1 cell line. Addition of the P-gp antagonist cyclosporin
A eﬃciently reversed the MDR phenotype, whereas no signif-
icant increase in doxorubicin uptake was observed in DU-
145Nox1 tumor spheroids. This clearly indicates that P-gp is
functional and renders DU-145 tumor spheroids drug resis-
tant.
If the elevated ROS levels in DU-145Nox1 tumor spheroids
are the cause for the observed decreased P-gp levels, neutral-
ization of ROS by free radical scavengers should reverse the
observed eﬀects. Furthermore, since it has been previously
demonstrated that the mdr-1 gene is under the control of
HIF-1a [8,31] this transcription factor should be downregu-
lated in DU-145Nox1 tumor spheroids. Indeed, it was demon-strated that DU-145Nox1 tumor spheroids not only displayed
decreased P-gp levels but likewise decreased levels of HIF-1a.
Incubation with free radical scavengers increased HIF-1a as
well as P-gp expression which clearly demonstrates that P-gp
expression in multicellular prostate tumor spheroids is regu-
lated by the intracellular ROS level. However, our data suggest
that the observed aﬀects of free radical scavengers on P-gp
expression were due to a decrease in protein turnover rather
than transcriptional activation since quantitative RT-PCR
data demonstrated that free radical scavengers failed to signif-
icantly upregulate mdr-1 mRNA neither in DU-145Nox1 tu-
mor spheroids nor in the parental cell line. These data are
corroborated by a recent study which demonstrated that free
radical scavengers did not increase HIF-1a gene expression
as evaluated by the use of a luciferase reporter construct under
the control of multiple HREs [7]. Since previous studies of our
group demonstrated that HIF-1a as well as P-gp protein
expression was increased following incubation with free radical
scavengers it may be suggested that the cellular ROS level reg-
ulates HIF-1a as well as P-gp protein stability rather than gene
expression [31].
Fig. 6. Eﬀects of the free radical scavengers vitamin C and vitamin E on HIF-1a (A) and P-gp (B) levels in DU-145 and DU-145Nox1 tumor
spheroids. Tumor spheroids were treated from day 6 to day 14 with vitamin C (30 lM) and vitamin E (100 lM) and subsequently analyzed by
semiquantitative immunohistochemistry for HIF-1a and P-gp expression. The representative images show: (a) DU-145 untreated; (b) DU-145 treated
with vitamins; (c) DU-145Nox1 untreated; (d) DU-145Nox1 treated with vitamins. Note, that treatment with free radical scavengers signiﬁcantly
increased HIF-1a and P-gp in DU-145Nox-1 tumor spheroids as compared to spheroids of the parental DU-145 cell line which displays already
maximum expression of HIF-1a and P-gp. The bar represents 150 lm. *P < 0.05 signiﬁcantly diﬀerent as compared to the untreated control.
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Fig. 7. Eﬀects of the free radical scavengers vitamin C and vitamin E
on mdr-1 mRNA expression in DU-145Nox1 (A) and DU-145 (B)
multicellular tumor spheroids. Note, that treatment of DU-145 as well
as DU-145Nox1 tumor spheroids with free radical scavengers did not
signiﬁcantly increase mdr-1 mRNA. *P < 0.05 signiﬁcantly diﬀerent as
compared to the untreated control.
4548 M. Wartenberg et al. / FEBS Letters 579 (2005) 4541–4549The eﬀect of ROS on P-gp expression is apparently dose-
dependent. We have previously shown that low concentrations
of ROS downregulated P-gp expression, whereas high concen-
trations which induce cell lethality after prolonged incubation
resulted in P-gp increase [32]. Increased P-gp expression on the
protein as well as transcriptional level following transient oxi-
dative stress has been shown to occur in primary cultured rat
brain endothelial cells [9]. Previously, it has been demonstrated
that upregulation of P-gp via nuclear factor-jB activation pro-
tects kidney proximal tubule cells from cadmium- and ROS-in-
duced apoptosis [24]. Stress-induced expression of P-gp has
been shown for various conditions, e.g. UV radiation [25],
low external pH, osmotic shock [33], and hyperthermia [29]
which may be associated with robust elevations of intracellular
ROS. ROS-mediated stress conditions have likewise been
shown to be involved in the regulation of HIF-1a expression
and/or stability [11]. In this respect, it was recently demon-
strated that the accumulation of H2O2 in junD/ cells de-
creases the availability of FeII and reduces the activity of
HIF prolyl hydroxylases that target hypoxia-inducible fac-
tors-a (HIF-a) for degradation [10]. Oxidative stress condi-
tions may elicit anti-apoptotic signaling pathway which are
distinct from those activated by low level ROS generation
and resulting in cell-cycle activation, increased tumor cell
growth and downregulation of P-gp expression. In these pre-
mises, the dissection of high level versus low level ROS-medi-ated signaling pathway appears inevitably necessary to
understand the regulation of P-gp and HIF-1a expression.
This is to the more important since HIF-1a not only controls
P-gp expression which limits the beneﬁt of chemotherapeutic
cancer but also vascular endothelial growth factor which is
a key determinant of vascularization of solid tumors during
tumor-induced angiogenesis.References
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